An off-stage interview with Benoit Lehallier, Head of Data Science at Alkahest Inc.

In his visionary keynote, Lehallier unveiled a groundbreaking approach to disease interception through molecular time travel. By harnessing deep biomarker profiling from a biobank of 100 million samples, advanced data science, and real-world data, Chronos is redefining the future of biomarker and drug discovery. A spotlight on the transformative collaboration with the Michael J. Fox Foundation in Parkinson’s disease illustrated the power of this paradigm to detect the earliest molecular signals of a wide range of conditions—well before symptoms emerge.